Mesenchymal stromal cells as cancer promoters
View abstract on PubMed
Summary
This summary is machine-generated.Mesenchymal stromal cells (MSCs) promote cancer progression by fostering tumor growth, blood vessel formation, and spread. Understanding these complex MSC-tumor interactions is key to improving cancer treatment strategies.
Area Of Science
- Oncology
- Cell Biology
- Cancer Research
Background
- Mesenchymal stromal cells (MSCs) are integral components of the tumor stroma.
- MSCs actively influence tumor development and progression.
- Complex interactions between MSCs and cancer cells create a pro-tumorigenic microenvironment.
Purpose Of The Study
- To review the mechanisms by which MSCs promote tumor growth.
- To evaluate the intricate cell-stromal interactions within the tumor microenvironment (TME).
- To elucidate the role of MSCs in cancer progression, angiogenesis, invasion, and metastasis.
Main Methods
- Literature review focusing on MSC-tumor interactions.
- Analysis of cellular heterogeneity and diversity in MSC isolation and culture.
- Evaluation of interactions between cancer cells, MSCs, TME components, and extracellular matrix (ECM).
Main Results
- MSCs create a milieu supporting tumor cell proliferation, angiogenesis, motility, invasion, and metastasis.
- Heterogeneity in MSCs and tumor subtypes complicates MSC-tumor interactions.
- Complex interplay exists between cancer cells, MSCs, TME, and ECM.
Conclusions
- A comprehensive understanding of MSC-mediated tumor promotion is crucial.
- Further research into MSC-tumor interactions can lead to enhanced cancer management strategies.
- Targeting MSCs within the TME may offer novel therapeutic avenues.
Related Concept Videos
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

